The Importance of Skin Disease as Assessed by “Willingness-To-Pay”
- 24 September 2003
- journal article
- research article
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 7 (5) , 369-371
- https://doi.org/10.1007/s10227-002-0145-y
Abstract
Background: To achieve optimal resource allocation in health care, it is necessary to value competing resource uses according to the benefit derived from those uses. Skin disease makes as great an impact as other serious medical conditions when assessed by effects on health-related quality of life. Objective: To confirm the high impact of skin disease by comparing patients’ willingness to pay (WTP) to be cured or relieved from symptoms of skin and nonskin conditions. Methods: We searched the published literature on WTP to compare the impact of dermatologic conditions with the impact of other medical conditions. A total of 46 articles were identified of which 10 included information on willingness to pay for cure reported on a monthly basis. Results: WTP for skin diseases fell in the range of $125–260/month and was comparable or higher than all but one of the other identified conditions. Conclusion: Willingness to pay for relief from skin diseases is comparable to that for relief of other serious medical conditions. Skin diseases are associated with a significant adverse impact on patients’ lives. En vue de parvenir à une allocation optimale des ressources médicales, il est nécessaire d’en évaluer les différents usages selon les avantages de chacun. La maladie de la peau a le même effet sur la qualité de vie que toute autre maladie grave. Objectif: Confirmer 1’impact important de la maladie de la peau en comparant la volonté de payer (VDP) des patients afin de soulager les symptômes associés aux maladies de la peau et ceux associés à d’autres maladies. Méthodes: Nous avons effectué des recherches sur les publications traitant de la VDP en vue de comparer l’impact des troubles dermatologiques avec l’impact d’autres sortes d’états pathologiques. En total, 46 articles ont été identifiés, dont 10 contiennent des données sur la volonté de payer pour une guérison sur une base mensuelle. Résultats: La VDP pour un trouble dermatologique varie entre 125 $ et 260 $ par mois, ce qui est comparable ou supérieur à toutes les autres pathologies, sauf une. Conclusion: La volonté de payer afin de soulager les conditions dermatologiques est comparable à celle la VDP pour soulager d’autres maladies graves. Les troubles de la peau peuvent avoir d’importants effets nuisibles sur la vie des patients.
Keywords
This publication has 14 references indexed in Scilit:
- Eliciting public preferences for healthcare: a systematic review of techniquesHealth Technology Assessment, 2001
- The burden of psoriasis: A study concerning health-related quality of life among Norwegian adult patients with psoriasis compared with general population normsJournal of the American Academy of Dermatology, 2000
- WILLINGNESS TO PAY IN TREATMENT OF BLEEDING DISORDERSInternational Journal of Technology Assessment in Health Care, 2000
- Willingness to pay and the valuation of programmes for the prevention and control of influenza.PharmacoEconomics, 1999
- Relationship Between Quality of Life Instruments, Health State Utilities, and Willingness to Pay in Patients with AsthmaAnnals of Allergy, Asthma & Immunology, 1998
- Postal questionnaire study of disability in the community associated with psoriasisBMJ, 1996
- Willingness to Pay for Reductions in Angina Pectoris AttacksMedical Decision Making, 1996
- Willingness to pay for antihypertensive therapy — further resultsJournal of Health Economics, 1993
- Economic evaluation of lipid lowering — A feasibility test of the contingent valuation approachHealth Policy, 1992
- How much disability is caused by acne?Clinical and Experimental Dermatology, 1989